Its like giving my body an extra push to optimize what Im already doing
Rigorous protocols use at least two orthogonal models (e.g., chemical lesion + transgenic) before claiming a generic cognitive effect
Lack of NP/MD oversight, unverifiable credentials, or refusal to share licensing information are major red flags
FIGURE 1 siRNA Knockdown of Grin1 in GLUTag Cells Increase GLP-1 Release In order to control for any possible off-target effects of MK-801which is known to also target acetylcholine receptors (nAChR), and to unequivocally confirm a direct role of NMDA receptor activity in the regulation of GLP-1 release from GLUTag cells, the essential NMDA receptor subunit, GluN1 (also called NMDAR1 or zeta-1), was knocked down by siRNA targeting of the gene Grin1, (Figure 2
Many of these improvements are likely related to better mobility, exercise endurance, and cardiovascular conditioning